Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy

被引:29
作者
Kim, Sang Soo [1 ,2 ]
Shin, Nari [3 ]
Bae, Sun Sik [4 ,5 ]
Lee, Min Young [1 ,2 ]
Rhee, Harin [1 ,2 ]
Kim, Il Young [6 ,7 ]
Seong, Eun Young [1 ,2 ]
Lee, Dong Won [6 ,7 ]
Lee, Soo Bong [6 ,7 ]
Kwak, Ihm Soo [1 ,2 ]
Lovett, David H. [8 ]
Song, Sang Heon [1 ,2 ]
机构
[1] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea
[2] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
[3] Pusan Natl Univ, Dept Pathol, Yangsan Hosp, Yangsan, Gyeongnam, South Korea
[4] Pusan Natl Univ, Sch Med, MRC Ischem Tissue Regenerat, Med Res Inst, Yangsan, South Korea
[5] Pusan Natl Univ, Sch Med, Dept Phamacol, Yangsan, South Korea
[6] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, Gyeongnam, South Korea
[7] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, Gyeongnam, South Korea
[8] Univ Calif San Francisco, San Francisco Dept Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94143 USA
关键词
OXIDATIVE STRESS; INHIBITION; INJURY;
D O I
10.1371/journal.pone.0171625
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background We recently reported on the enhanced expression of two isoforms of matrix metalloproteinase-2 (MMP-2) in human renal transplantation delayed graft function. These consist of the conventional secreted, full length MMP-2 isoform (FL-MMP-2) and a novel intracellular N Terminal Truncated isoform (NTT-MMP-2) generated by oxidative stress-mediated activation of an alternate promoter in the MMP-2 first intron. Here we evaluated the effect of hyperglycemia and diabetes mellitus on the in vitro and in vivo expression of the two MMP-2 isoforms. Methods We quantified the abundance of the FL-MMP-2 and NTT-MMP-2 transcripts by qPCR in HK2 cells cultured in high glucose or 4-hydroxy-2-hexenal (HHE) and tested the effects of the NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC). The streptozotocin (STZ) murine model of Type I diabetes mellitus and renal biopsies of human diabetic nephropathy were used in this study. Results Both isoforms of MMP-2 in HK2 cells were upregulated by culture in high glucose or with HHE. PDTC treatment did not suppress high glucose -mediated FL-MMP-2 expression but potently inhibited NTT-MMP-2 expression. With STZ-treated mice, renal cortical expression of both isoforms was increased (FL-MMP-2, 1.8-fold; NTT-MMP-2, greater than 7-fold). Isoform-specific immunohistochemical staining revealed low, but detectable levels of the FL-MMP-2 isoform in controls, while NTT-MMP-2 was not detected. While there was a modest increase in tubular epithelial cell staining for FL-MMP-2 in STZ-treated mice, NTT-MMP-2 was intensely expressed in a basolateral pattern. FL-MMP-2 and NTT-MMP-2 isoform expression as quantified by qPCR were both significantly elevated in renal biopsies of human diabetic nephropathy (12 -fold and 3 -fold, respectively). Conclusions The expression of both isoforms of MMP-2 was enhanced in an experimental model of diabetic nephropathy and in human diabetic nephropathy. Selective MMP-2 isoform inhibition could offer a novel approach for the treatment of diabetic renal disease.
引用
收藏
页数:14
相关论文
共 19 条
[1]   Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB [J].
Alfonso-Jaume, Maria Alejandra ;
Bergman, Marina R. ;
Mahimkar, Rajeev ;
Cheng, Sunfa ;
Jin, Zhu Q. ;
Karliner, Joel S. ;
Lovett, David H. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (04) :H1838-H1846
[2]  
[Anonymous], 2014, NAT DIAB STAT REP ES
[3]   Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus [J].
Chang, Chih-Min ;
Hsieh, Ching-Jung ;
Huang, Ju-Chun ;
Huang, I-Chin .
ACTA DIABETOLOGICA, 2012, 49 :S171-S177
[4]   Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation [J].
Cheng, SF ;
Lovett, DH .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1937-1949
[5]   Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury [J].
Cheng, Sunfa ;
Pollock, Allan S. ;
Mahimkar, Rajeev ;
Olson, Jean L. ;
Lovett, David H. .
FASEB JOURNAL, 2006, 20 (11) :1898-+
[6]   Matrix metalloproteinases as drug targets in ischemia/reperfusion injury [J].
Dejonckheere, Eline ;
Vandenbroucke, Roosmarijn E. ;
Libert, Claude .
DRUG DISCOVERY TODAY, 2011, 16 (17-18) :762-778
[7]   The pathogenesis of diabetic nephropathy [J].
Dronavalli, Suma ;
Duka, Irena ;
Bakris, George L. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (08) :444-452
[8]   Oxidative stress as a major culprit in kidney disease in diabetes [J].
Forbes, Josephine M. ;
Coughlan, Melinda T. ;
Cooper, Mark E. .
DIABETES, 2008, 57 (06) :1446-1454
[9]   Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix [J].
Kandasamy, Arulmozhi D. ;
Chow, Ava K. ;
Ali, Mohammad A. M. ;
Schulz, Richard .
CARDIOVASCULAR RESEARCH, 2010, 85 (03) :413-423
[10]   Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury [J].
Kunugi, Shinobu ;
Shimizu, Akira ;
Kuwahara, Naomi ;
Du, Xuanyi ;
Takahashi, Mikiko ;
Terasaki, Yasuhiro ;
Fujita, Emiko ;
Mii, Akiko ;
Nagasaka, Shinya ;
Akimoto, Toshio ;
Masuda, Yukinari ;
Fukuda, Yuh .
LABORATORY INVESTIGATION, 2011, 91 (02) :170-180